載入...
O(6)-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma
BACKGROUND: Treatment of glioblastoma (GB), the most common malignant primary brain tumor in adults, can include alkylating chemo-therapeutic agents. Two molecular biomarkers of treatment response are MGMT (O(6)-methylguanine-DNA methyltransferase) promoter methylation and IDH (isocitrate dehydrogen...
Na minha lista:
| 發表在: | Ann Saudi Med |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
King Faisal Specialist Hospital and Research Centre
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6894451/ https://ncbi.nlm.nih.gov/pubmed/31804140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5144/0256-4947.2019.410 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|